Boomerang dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1263OMIM:112310Q87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Boomerang dysplasia is an extremely rare and lethal skeletal disorder (osteochondrodysplasia) characterized by severe dwarfism and distinctive skeletal abnormalities that are apparent prenatally or at birth. The name derives from the characteristic boomerang-shaped appearance of the long bones, particularly the femora, seen on radiographic imaging. This condition is caused by heterozygous mutations in the FLNB gene (filamin B), which plays a critical role in skeletal development and cartilage formation. Boomerang dysplasia is considered the most severe condition within the spectrum of FLNB-related skeletal disorders, which also includes atelosteogenesis types I and III and Larsen syndrome. The disease profoundly affects the skeletal system, with key features including severe limb shortening (micromelia), underossification (reduced mineralization) of the vertebral bodies and limb bones, absent or severely hypoplastic long bones with the characteristic boomerang shape, encephalocele (protrusion of brain tissue through the skull), and distinctive facial features including a flat midface, widely spaced eyes (hypertelorism), and a depressed nasal bridge. Additional findings may include omphalocele, finger and nail abnormalities, and dislocated joints. The thorax is often narrow and underdeveloped. Boomerang dysplasia is uniformly lethal, with affected individuals typically dying in utero or in the early neonatal period due to respiratory insufficiency related to the severely underdeveloped thorax and lungs. There is no curative treatment available. Management is limited to supportive and palliative care. Prenatal diagnosis may be possible through ultrasound identification of the characteristic skeletal abnormalities and can be confirmed by molecular genetic testing of the FLNB gene. Genetic counseling is recommended for affected families.

Clinical phenotype terms— hover any for plain English:

Abnormal humerus morphologyHP:0031095Aplasia/Hypoplasia of the fibulaHP:0006492Severe short-limb dwarfismHP:0008890Abnormal bone ossificationHP:0011849Abnormally ossified vertebraeHP:0100569Poorly ossified vertebraeHP:0100856Abnormal morphology of the radiusHP:0002818Aplasia/Hypoplasia of the abdominal wall musculatureHP:0010318
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Boomerang dysplasia.

View clinical trials →

No actively recruiting trials found for Boomerang dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Boomerang dysplasia community →

No specialists are currently listed for Boomerang dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Boomerang dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Boomerang dysplasiaForum →

No community posts yet. Be the first to share your experience with Boomerang dysplasia.

Start the conversation →

Latest news about Boomerang dysplasia

No recent news articles for Boomerang dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Boomerang dysplasia

What is Boomerang dysplasia?

Boomerang dysplasia is an extremely rare and lethal skeletal disorder (osteochondrodysplasia) characterized by severe dwarfism and distinctive skeletal abnormalities that are apparent prenatally or at birth. The name derives from the characteristic boomerang-shaped appearance of the long bones, particularly the femora, seen on radiographic imaging. This condition is caused by heterozygous mutations in the FLNB gene (filamin B), which plays a critical role in skeletal development and cartilage formation. Boomerang dysplasia is considered the most severe condition within the spectrum of FLNB-rel

How is Boomerang dysplasia inherited?

Boomerang dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Boomerang dysplasia typically begin?

Typical onset of Boomerang dysplasia is neonatal. Age of onset can vary across affected individuals.